Clinical Features and Prognostic Impact of Coexpression Modules Constructed by WGCNA for Diffuse Large B-Cell Lymphoma

Abstract

Objective. Diffuse large B-cell lymphoma (DLBCL) is a highly aggressive malignant tumor, accounting for 30-40% of non-Hodgkin’s lymphoma. Our aim was to construct novel prognostic models of candidate genes based on clinical features. Methods. RNA-seq and clinical data of DLBCL were retrieved from TCGA database. Coexpression modules were constructed by WGCNA. Then, we investigated the interactions between modules and clinical features. By overall survival analysis, prognostic candidate genes from modules of interest were identified. A coexpression network of prognostic candidate genes was then constructed through WGCNA. GEPIA was used to analyze the expression of a candidate gene between DLBCL and normal samples. Results. 19 coexpression modules were constructed by 12813 genes from 52 DLBCL samples. The number of genes in modules ranged from 34 to 5457. We found that the purple module was significantly related with histological type (p value = 1e-04). Overall survival analysis revealed that MAFA-AS1, hsa-mir-338, and hsa-mir-891a were related with prognosis of DLBCL (p value = 0.027, 0.039, and 0.022, respectively). A coexpression network was constructed for the three prognostic genes. MAFA-AS1 was interacted with 36 genes, hsa-mir-891a was interacted with 11 genes, while no gene showed interaction with hsa-mir-338. Using GEPIA, we found that MAFA-AS1 showed low expression in DLBCL samples (p<0.01). Conclusion. We constructed a coexpression module related with histological type and identified three candidate genes (MAFA-AS1, hsa-mir-338, and hsa-mir-891a) that possessed potential value as prognostic biomarkers and therapeutic targets of DLBCL.

Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma

“…These DEGs were also associated with ccRCC occurrence and development, such as cell adhesion molecules, focal adhesion, ECM-receptor interaction, and HIF-1, PI3K-AKT, P53, and Rap1 signaling pathways. Cell adhesion molecules can mediate cellular adhesion to control cell motility and transduce intracellular signaling [ 31 ], and focal adhesion also can control cell morphology, adhesion, and migration by connecting the ECM and intercellular F-actin [ 32 ], both of which are accordingly important for cancer invasion and metastasis, and are critical determinants in cancer cell resistance to therapy [ 33 ]. There is evidence that a positive feedback loop between the PI3K-AKT and HIF-1 pathways is involved in ccRCC tumorigenesis [ 9 ].…”

ANO6 is a reliable prognostic biomarker and correlates to macrophage polarization in breast cancer

“…Cell adhesion molecules can mediate cell adhesion, control cell motility, and conduct intracellular signals. [ 25 ] Besides, focal adhesion can control cell morphology, adhesion, and migration by linking ECM and intracellular F-actin. [ 26 ] These are essential for cancer invasion, metastasis, and resistance to cancer therapy.…”

Integrated bioinformatics analysis reveals dynamic candidate genes and signaling pathways involved in the progression and prognosis of diffuse large B-cell lymphoma

“…The few bioinformatics analyses on DLBCL focused on the subtypes ( Huang, Liu & Shen, 2019 ; Zhou et al, 2020 ) or clinical features ( Xiao, Wang & Bai, 2020 ). However, some dysregulated genes specific to DLBCL versus non-tumor controls cannot distinguish the subtypes ( Huang, Liu & Shen, 2019 ).…”